The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain

Camilla Kristine Appel(University of Copenhagen), Anne‐Marie Heegaard(University of Copenhagen)
Scientific Reports
June 30, 2017
Cited by 35


Related Papers